Schwannomatosis is a recently delineated inherited condition that has clinical overlap with neurofibromatosis type 2 (NF2). Diagnostic criteria have been developed to distinguish schwannomatosis from NF2, but the existence of mosaic NF2, which may ...
Kulkarni, Anjana +17 more
core +1 more source
Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis
Background: Schwannomatosis is a rare condition characterised by multiple schwannomas and lack of involvement of the vestibular nerve. A recent report identified bi-allelic mutations in the SMARCB1/INI1 gene in a single family with schwannomatosis.
Hadfield, K. D. +9 more
core +1 more source
Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria
Schwannomatosis is the third major form of neurofibromatosis and is characterized by the development of multiple schwannomas in the absence of bilateral vestibular schwannomas.
Kalpana, Ganjam V. +15 more
core +1 more source
Clinical severity grading of NF2-related schwannomatosis
Background NF2-related schwannomatosis (NF2) is associated with various tumors of the central and peripheral nervous system. There is a wide range of disabilities these patients may suffer from and there is no validated clinical classification for ...
Anna C. Lawson McLean +4 more
doaj +1 more source
Plexiform schwannoma in schwannomatosis
Shinde, S. V. +3 more
openaire +2 more sources
SMARCA4-associated schwannomatosis
Fiona Chan-Pak-Choon +12 more
openaire +2 more sources
Clinical and Imaging Phenotype of Schwannomatosis in Children, Adolescents and Young Adults. [PDF]
Ahlawat S +7 more
europepmc +1 more source
Stereotactic radiosurgery for NF2-related schwannomatosis and schwannomatosis-associated spinal tumors: a single-institution cohort. [PDF]
Sanker V +9 more
europepmc +1 more source
Malignant peripheral nerve sheath tumors arising in SMARCB1-associated schwannomatosis: illustrative cases. [PDF]
Khalilullah T +12 more
europepmc +1 more source
New Approaches to Clinical Trials for Rare Diseases: Decentralized Trial Design for Neurofibromatosis Type 1 and Schwannomatosis. [PDF]
Merker VL +18 more
europepmc +1 more source

